| Trial ID: | L0714 |
| Source ID: | NCT00004429
|
| Associated Drug: |
Growth Hormone
|
| Title: |
Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic
|
| Interventions: |
DRUG: growth hormone
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: FDA Office of Orphan Products Development | Collaborators: Vanderbilt University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
25
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
1999-12
|
| Completion Date: |
2005-02
|
| Results First Posted: |
|
| Last Update Posted: |
2015-03-25
|
| Locations: |
Vanderbilt University Medical Center, Nashville, Tennessee, 37232-2516, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00004429
|
